Evidence map›Paper›PMID 36745269›Full record

ReviewNeurochemical research2023

Neuroprotective Roles of Apelin-13 in Neurological Diseases.

Yang Zhang, Weiwei Jiang, Wenjie Sun, Weiming Guo, Beibei Xia, Xiangru Shen, Mingyuan Fu, Teng Wan, Mei Yuan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yang Zhang *Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Weiwei Jiang *Hengyang Medical College, University of South China, Hengyang, 421001, Hunan, China.
Wenjie Sun *Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Weiming GuoDepartment of Sports Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518060, China.
Beibei XiaHengyang Medical College, University of South China, Hengyang, 421001, Hunan, China.
Xiangru ShenHengyang Medical College, University of South China, Hengyang, 421001, Hunan, China.
Mingyuan FuHengyang Medical College, University of South China, Hengyang, 421001, Hunan, China.
Teng Wan *Department of Neurology, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518060, China. wanteng@xuehaiwuya.club.
Mei Yuan *Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. meimeihaijun@163.com.
University of South China · CNHuazhong University of Science and Technology · CNShenzhen University Health Science Center · CN

Funding

Key Project of Hunan provincial science and technology innovation NO.2020SK1012Natural Science Foundation of Hunan Province 2022JJ30523Program of Hunan Health Commission 202203072849
6 · The paper itself

Abstract

Apelin is a natural ligand for the G protein-coupled receptor APJ, and the apelin/APJ system is widely distributed in vivo. Among the apelin family, apelin-13 is the major apelin isoform in the central nervous system and cardiovascular system, and is involved in the regulation of various physiopathological mechanisms such as apoptosis, neuroinflammation, angiogenesis, and oxidative stress. Apelin is currently being extensively studied in the nervous system, and apelin-13 has been shown to be associated with the onset and progression of a variety of neurological disorders, including stroke, neurodegenerative diseases, epilepsy, spinal cord injury (SCI), and psychiatric diseases. This study summarizes the pathophysiological roles of apelin-13 in the development and progression of neurological related diseases.

Indexed as

Intercellular Signaling Peptides and ProteinsNervous System DiseasesApelinApelin ReceptorsHumansReceptors, G-Protein-CoupledApelinapelin-13 peptideApelin ReceptorsIntercellular Signaling Peptides and ProteinsReceptors, G-Protein-CoupledApelin-13ApoptosisNeuroinflammationNeurological diseasesNeuroprotection

Identifiers

PMID36745269
OpenAlexW4319294294

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.